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ABSTRACT 
 
Evaluation of Mares as a Source of Rhodococcus equi for Their Foals Using Quantitative 
Culture and a Colony Immunoblot Assay.  (August 2006) 
Michael Bradley Grimm, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Noah Cohen 
 
 Fecal specimens from 130 different mares were collected from an endemic farm 
for 2 consecutive years at 4 different times pre- and post-foaling (41 mares contributed 
data in both years).  A modified NANAT agar medium was used to quantitatively culture 
1-g aliquots of the mare feces without inhibition of growth of Rhodococcus equi.  Once 
the R. equi in the mare feces were quantified and the total concentrations of R. equi 
determined, a colony immunoblot procedure was performed to detect the presence of the 
virulence-associated protein antigen on the isolates.  This allowed for the proportion and 
concentration of virulent R. equi to be determined.  Foals that were found to have 
ultrasonographic evidence of peripheral pulmonary abscessation or consolidation 
underwent aseptic trans-cutaneous tracheobronchial aspiration.  Positive results of TBA 
were used to categorize foals as affected with R. equi pneumonia.  R. equi pneumonia 
developed in 31% of the foals.  Shedding of virulent R. equi was observed in at least 1 
sampling period for every mare examined, and >33% were culture-positive during all 
sampling periods.  However, significant differences were not observed in either the fecal 
concentrations of total or virulent R. equi from dams of affected foals compared to dams 
of unaffected foals.  No significant temporal changes in the fecal concentrations 
iv 
of R. equi were observed.  It was concluded that dams of affected foals do not shed more 
R. equi in feces than do dams of unaffected foals, indicating that heavier shedding by 
particular mares does not explain infection in their foals.  However, the finding that 
virulent R. equi were excreted in the feces of all sampled mares indicates that mares are 
likely an important source of R. equi for their surrounding environment. 
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CHAPTER I 
 
INTRODUCTION 
 
 
 
Rhodococcus equi is a facultative-intracellular organism and an important cause 
of disease and death among foals, particularly at endemic farms.1  R. equi is primarily a 
soil saprophyte with growth requirements that are met by herbivore manure and warm 
climates.2  R. equi can be cultured from the feces of mature horses,3 and foals as young as 
3 days of age.4  In 1923, it was first described from as the causative agent of 
pyogranulomatous pneumonia from young foals in Sweden.5  Today, R. equi is 
considered the most common cause of severe pneumonia in foals and can be isolated 
from a number of different types of specimens including feces, soil, and tracheobronchial 
fluid.  It has been suggested that R. equi is likely part of the normal flora of the equine 
lower gastrointestinal tract.3  
Foal pneumonia caused by R. equi is endemic on some farms, intermittent on 
others, and absent on most farms.6  Anecdotally, dams of some foals have been reported 
to have multiple affected foals, while foals of other mares from the same environment are 
consistently unaffected.7  Recent epidemiological evidence indicates that foals with 
spontaneous R. equi pneumonia become infected early in life,8 although the source of 
infection for foals remains unknown.  Several previous studies have supported the notion 
of mare feces as a potential source of R. equi in the environment and possibly a direct                       
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source for their foals.  For example, the prevalence of R. equi in feces of mares was 
similar for 2 farms in Kansas with recent cases of R. equi pneumonia (14%) and an 
unaffected control farm (31%).9  In a report from Australia, the prevalence of fecal 
shedding of R. equi among 127 horses was 71%.10  Furthermore, in a study of 43 foals 
from 2 farms in Japan, the prevalence of fecal shedding was high among foals from an R. 
equi-endemic farm (94%; 16/17) and a farm with no history of R. equi pneumonia (73%; 
19/26).11  The mean concentration of R. equi per gram of feces was similar among foals 
from the 2 farms (104/g feces).  In 2 foals that developed disease, fecal concentrations of 
R. equi were observed to increase.  The organism has been isolated from feces of foals <1 
week of age and fecal shedding among foals has been shown to increase with age.12-14  
Evidence from Japan has revealed a seasonal variation in shedding of R. equi in feces of 
mares, with the highest concentrations of R. equi shedding during the spring (foaling 
season), although the average number of organisms shed by mares during the 5-week 
periods pre- and post-foaling was not significantly different.12
Expression of the virulence-associated protein antigen (VapA) by R. equi is 
strongly associated with disease in foals; the vapA gene encoding this protein is located 
on an 85-90 kb plasmid (VapA-P).4,6,15  Because only virulent organisms are considered 
to cause disease, it is important to consider the virulence status of isolates in 
epidemiologic studies of R. equi.  In a study of 2 breeding farms in Japan, the prevalence 
of virulent organisms was greater among foals at an R. equi-endemic farm than an 
unaffected farm, although differences were not observed in the prevalence of virulent 
isolates in the feces of their dams.16
3 
Given the high prevalence of R. equi fecal shedding by foals, large volume of 
feces passed by adult horses, and an increased prevalence of R. equi shedding by dams 
during the foaling season, it is plausible that a dam may be an important source of 
virulent R. equi for her foal.  The purpose of this study is to determine if dams of foals 
affected with R. equi pneumonia shed more R. equi in their feces than dams of foals that 
remain unaffected with R. equi pneumonia.   
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CHAPTER II 
 
EVALUATION OF MARES AS A SOURCE OF Rhodococcus equi FOR THEIR 
FOALS USING QUANTITATIVE CULTURE AND A COLONY IMMUNOBLOT 
ASSAY 
 
Introduction 
Rhodococcus equi is a facultative-intracellular organism and an important cause 
of disease and death among foals, particularly at endemic farms.1-4  R. equi is primarily a 
soil saprophyte with growth requirements that are met by herbivore manure and warm 
climates.2  R. equi can be cultured from the feces of mature horses,3 and foals as young as 
3 days of age.4  It has been suggested that R. equi is likely part of the normal flora in the 
equine lower gastrointestinal tract.3  
Foal pneumonia caused by R. equi is endemic on some farms, intermittent on 
others, and absent on most farms.2,6  Anecdotally, some mares have reportedly had 
multiple affected foals, while foals of other mares from the same environment are 
consistently unaffected.7  Epidemiological evidence indicates that foals with spontaneous 
R. equi pneumonia become infected early in life.8  The source of infection for foals 
remains unknown.  Results of previous studies indicate that the feces of mares is a 
potential source of R. equi for the environment and possibly a direct source of infection 
for foals.  Rhodococcus equi has been isolated from the feces of mares at 2 breeding 
farms in the United States.9  In a report from Australia, the prevalence of fecal shedding 
of R. equi among 127 horses was 71%.10  Evidence from Japan has revealed a seasonal 
variation in shedding of R. equi in feces of mares, with the highest levels of R. equi 
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shedding during the spring (foaling season), although the average number of organisms 
shed by mares during the 5-week-periods before and after foaling was not significantly 
different.12  
Expression of the virulence-associated protein antigen (VapA) by R. equi is 
strongly associated with disease in foals; the vapA gene is located on an 85-90 kb plasmid 
(VapA-P). 4,6,15 Because only virulent organisms are considered to cause disease, it is 
important to consider the virulence status of isolates in epidemiologic studies of R. equi. 
In a study of 2 breeding farms in Japan, the prevalence of virulent organisms in feces was 
greater among foals at an R. equi-endemic farm than at an unaffected farm, although 
differences were not observed in the prevalence of virulent isolates in the feces of their 
dams.16  To the authors’ knowledge, no studies have been reported in which the 
concentration of virulent R. equi in fecal samples of mares or foals was determined and 
for which the association of these concentrations with disease in foals caused by this 
bacterium was examined. 
Given the high prevalence of R. equi in feces of breeding mares, the large volume 
of feces passed by adult horses, and the reported increased prevalence of R. equi shedding 
by mares during the foaling season, it is plausible that a mare could be an important 
source of virulent R. equi for her foal.  The primary objective of this study was to 
examine the association between R. equi pneumonia status of the foal and shedding of 
virulent R. equi by its dam.  To address this objective, fecal specimens were collected for 
2 years from mares at a single farm with a history of recurrent R. equi pneumonia at 
specified time-points pre- and post-foaling, and fecal concentration of total and virulent 
R. equi was quantified for each sample.  Fecal concentrations of total and virulent R. equi 
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were compared between mares of foals that subsequently developed R. equi pneumonia 
and mares of foals that did not develop pneumonia.  Comparisons were made for 
concentrations at each sampling time, and for the 6 differences among the 4 different 
sampling times.   
 
Materials and Methods 
Study population and fecal sample collection - Mares and their foals from a farm in 
central Kentucky with endemic R. equi pneumonia served as the study population.  Only 
mares whose foals were born alive and resided at the farm from birth through weaning 
were included in the study.  The rationale for this inclusion criterion was to ensure 
consistent monitoring for development of R. equi pneumonia by 2 of the authors (NMS 
and GDM).  Fecal samples were collected from mares at the following time-points before 
and after foaling: approximately 2 weeks prior to foaling; approximately 1 week prior to 
foaling; the day of foaling; and 1 week after foaling.   
Fecal samples were collected either from the top of a fresh fecal pile observed to 
have been voided in the stall or by manual evacuation of feces from the rectum.  
Following collection, fecal samples were refrigerated at 4ºC until shipped and transported 
within 48 hr of collection in insulated containers with icepacks.  During 2004, fecal 
samples were frozen at -20ºC upon arrival and prior to culture.  During 2005, quantitative 
culture of feces was performed on fresh samples either on the day of arrival or the 
following day for samples that arrived late in the day; specimens cultured the next day 
were maintained under refrigeration.  The reason for the discrepancy in specimen 
handling was that sample collection was initiated in 2004 prior to funding for the project; 
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samples initially were saved frozen in the event that the study could not be conducted 
because of lack of funding.  When funding was obtained, the investigators elected to 
freeze all fecal samples for 2004 so that they would be processed in a consistent manner.   
 
Microbiologic culture of R. equi -  A 1-g aliquot of each fecal specimen was mixed 
thoroughly with 5 ml phosphate-buffered salinea (PBS) in order to evenly distribute 
organisms present in the sample.  Quantitative culture of the fecal suspensions was 
performed using a modified R. equi selective agar medium,10 developed by a coauthor 
(ST).  The modified NANAT agar medium consisted of the following: 300 ml boiled beef 
broth; 600 ml distilled water; 20 g peptone;b 5 g sodium chloride;c 5 g yeast extract;d 5 g 
glucose;e 0.2 g sodium dithionite;f 1.2 g sodium thiosulfate;g 2 g potassium phosphate;h 2 
g sodium bicarbonate;i and 15 g technical agar.j  The pH was adjusted to 7.2 and 
autoclaved at 121.6ºC for 30 min.  The medium was allowed to cool to 55ºC before the 
following antibiotics were added: 25 µg/ml novobiocin;k 40 µg/ml cycloheximide;l 20 
µg/ml nalidixic acid;m and 3.5% potassium tellurite.n  Although either beef broth or horse 
meat broth can be used in this formulation, in this study beef broth was prepared using 
approximately 1.1 kg (2.5 lb) of lean ground beef mixed with 5 L of distilled water and 
incubated overnight at 4ºC.  The mixture was then boiled for 2 hr, cooled at room 
temperature, and stored at 4ºC until completely cooled.  The solidified fat was removed 
from the surface and broth was strained through gauze to remove residual fat and meat.  
The broth was then autoclaved at 121.6ºC for 30 min, and stored at 4ºC. 
The use of the modified NANAT agar medium effectively minimized concomitant 
growth of bacterial and fungal contaminants.  To examine the possibility of R. equi 
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growth inhibition on the modified NANAT agar, virulent and plasmid-cured (avirulent) 
R. equi bacterial strains were quantitatively cultured on the NANAT agar medium from 
minimal media.18 Growth of each R. equi strain appeared uninhibited on the NANAT 
agar in both pure culture and after mixing with equine fecal material to mimic other 
potential growth-inhibiting sources.o  
Ten-fold serial dilutions of the fecal/PBS suspensions were prepared and cultured 
in duplicate for all samples.  A 100 µl volume of the fecal suspension was inoculated 
onto the surface of a NANAT medium agar plate and evenly dispersed using a sterile 
plate spreader.  Both positive and negative controls were implemented to ensure validity 
of the results.  The positive controls consisted of pure culture virulent R. equi (ATCC 
strain 33701) grown in R. equi minimal media18 to approximately 108 colony forming 
units (cfu) per ml and 1 g of feces inoculated with approximately 108 cfu of virulent R. 
equi.  Ten-fold serial dilutions were performed on both of the positive controls, and 100 
ul of the dilution containing approximately 100 cfu/ml of virulent R. equi were plated 
onto separate agar plates.  The negative controls consisted of 100 µl of R. equi minimal 
media (used to make the pure cultures) and 100 µl of PBS (used to resuspend feces for 
quantitative culture).  All quantitative culture controls were plated on the modified 
NANAT agar medium used for all other samples in this study.   
Fecal culture plates were allowed to incubate at 34°C for 48 hrs.  The dilution 
containing between 15 and 150 cfu of R. equi per culture plate was counted, and these 
same plates were used for colony immunoblotting.  The number of cfu on a plate were 
multiplied by the dilution factors (and divided by 1) to determine the concentration of R. 
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equi in feces.  The average concentration of cfu/g of R. equi in feces of the 2 duplicates 
was determined and used for analysis.  
 
Modified colony immunoblot assay - The concentration of virulent R. equi in feces was 
determined by modifying an immunoblotting technique for detecting VapA.19  Colony 
immunoblotting, using a monoclonal antibody for VapA, has been previously used to 
determine the virulence status of 3 to 10 R. equi colonies subcultured from their original 
agar plates.20,21  This approach was modified for this study to allow quantification of  the 
concentration of virulent R. equi within a background of bacterial and fungal 
contamination.  Nitrocellulose membranesp were placed onto previously incubated 
NANAT agar culture plates containing between 15 and 150 cfu of R. equi, and allowed to 
become completely saturated.  Once saturated, membranes were removed, air-dried at 
room temperature for 30 min, and baked in an ovenq at 100ºC for 1 min.  The 
nitrocellulose membranes were incubated in 5% non-fat dry milkr for 60 min at 37ºC to 
block any unbound sites.  The membranes were then washed 3 times with 0.05% Tween 
20s in tris-buffered salinet (TBST).  The membranes were incubated overnight at 4ºC on a 
rockeru with the monoclonal antibody (Mab)v diluted 1:10,000 in 5% non-fat dry milk.  
The membranes were washed for 10 min at 37°C with fresh TBST a total of 3 times. 
Horseradish peroxidase-conjugated goat immunoglobulin G fraction to mouse 
immunoglobulin Gw was diluted 1:2,000 in 5% non-fat dry milk and added to the 
membranes, followed by a 1 hr incubation at 37ºC.  The membranes were again washed 
for 10 min at 37°C with fresh TBST a total of 3 times.  The membranes were then 
washed once with citrate-ethylenediaminetetraacetic acid (EDTA) buffer (10 mM sodium 
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citratex and 10 mM EDTAy) (pH=5.0) for 5 min at 37°C, once with citrate-EDTA buffer 
+ 1% dextran sulfatez for 10 min at 37°C, and 3 times with citrate-EDTA buffer for 5 min 
at 37°C.  The substrates 3,3’,5,5’-tetramethylbenzidine (TMB)aa and hydrogen peroxide 
were added to the membranes followed by a 30 min incubation at 37°C.  The substrate 
was discarded and distilled water was added to stop development.  Virulent R. equi 
colonies appeared blue, while the avirulent R. equi colonies and contaminates remained 
colorless.  This colony immunoblotting method was validated by using both virulent and 
avirulent strains of R. equi.  The immunoblotting method and a previously described 
colony picking method16,22,23 of each strain of R. equi, grown on NANAT agar medium 
from minimal media,18 were performed. In addition, plates of R. equi-negative feces 
experimentally inoculated with virulent or avirulent R. equi were also colony 
immunoblotted by directly placing a nitrocellulose membrane onto the agar plate to 
validate proper selectivity of the Mab to virulent R. equi isolates.  Confirmation that only 
virulent R. equi colonies were immunoblot-postitive was made prior to implementation of 
this technique.o  Positive and negative controls were also included along with each batch 
of colony immunoblots.  The positive and negative controls were NANAT agar medium 
plates grown from pure culture of virulent and avirulent R. equi in minimal media,18 
respectively.  Ten-fold serial dilutions were performed on the pure culture virulent and 
avirulent R. equi using PBS and 100 µl of the dilution containing approximately 104 
cfu/ml were individually plated.  All colony immunoblot control plates were incubated 
under the same conditions as the quantitative culture control plates and the fecal 
specimen plates.  The proportion of virulent isolates in the fecal specimen plates were 
determined by dividing the total number of virulent colonies counted from both duplicate 
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plates by the total number of R. equi colonies that were present on both duplicate plates 
prior to the colony immunoblotting portion.  Concentration of virulent isolates was 
determined by multiplying the proportion of virulent isolates by the concentration of R. 
equi present in the fecal sample.  
  
Determining R. equi pneumonia status of foals – Beginning in the first week of life, foals 
were monitored daily by visual inspection for abnormalities (such as elevated respiratory 
rate or effort, joint swelling, etc.,) and assessment of rectal temperature; physical 
examination was performed immediately if fever (Temp >38.9ºC [>102oF]) or physical 
abnormalities were detected by inspection.  Thoracic ultrasonography began at 
approximately 2-weeks of age, to identify peripheral pulmonary abscessation, 
consolidation, or other abnormalities such as irregularities of the pleural surface, and was 
repeated at 2-week time-points until weaning (16-20 wk).  Additionally, foals underwent 
thoracic ultrasonography within 48 hours if a fever or other physical abnormality was 
detected during daily screening.  Each foal included in the study was assigned an 
ultrasound score based on sonographic findings, using a proposed scoring sytem.bb  For 
purposes of this study, ultrasound scores for the thorax were categorized as no lesions, 
lesions of total scores of 1 to 3, or lesions with score >3.  Foals that were found to have 
ultrasonographic evidence of peripheral pulmonary abscessation or consolidation 
underwent aseptic trans-cutaneous tracheobronchial aspiration (TBA).  For purposes of 
this study, a case of R. equi pneumonia was defined as a foal >2 weeks of age with 
ultrasonographic evidence of pulmonary abscessation or consolidation and isolation of R. 
equi from TBA or gram-positive intracellular coccobacilli observed in cytology of TBA 
12 
fluid.  Foals that had clinical signs of R. equi infection and from which either R. equi was 
isolated from a TBA or gram-positive intracellular coccobacilli were observed in 
cytology of TBA fluid were also included as cases.  Clinical signs of early detection of R. 
equi pneumonia included: increased fever and respiratory rate, coughing, wheezing, and 
nasal discharge.24-26  
 
Data analysis - The data were summarized using medians and interquartile (IQ) ranges 
(ie, the range from the 25th to the 75th percentiles of the data) for continuous data (such as 
concentrations or proportions of virulent organisms) and contingency tables for 
categorical data.  Continuous variables were compared using the Wilcoxon rank-sum test 
(for comparison of 2 samples) or the Kruskal-Wallis test (for comparisons of >2 samples) 
because these data generally appeared non-Gaussian.  Categorical variables were 
compared using either the χ2 test or, when appropriate, Fisher’s exact test.  Because 
multiple comparisons were made, the method of Holm for adjustment was used to retain 
an overall significance level of P < 0.05 when any comparison was identified as being 
statistically significant.27  Analyses were conducted using commercial software.cc
 
Results  
There were 94 and 77 mares that had foals residing through weaning at the farm 
in 2004 and 2005, respectively; 41 mares contributed data in both years such that there 
were 130 different mares during the 2-year period of the study.  During 2004, the 94 
mares contributed 365 fecal samples (97% of a total of 376 [94 x 4] possible samples): 
there were 2, 4, 2, and 3 samples missed from mares at the sampling periods 2 weeks 
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prior to foaling, 1 week prior to foaling, day of foaling, and 1 week after foaling, 
respectively.  During 2005, the 77 mares contributed 286 fecal samples (93% of a total of 
308 [77 x 4] possible samples): there were 0, 4, 10, and 8 samples missed from mares at 
the same sampling periods, respectively as above.  Because samples were processed 
differently in 2004 and 2005 (ie, frozen vs fresh cultures), the effects of year on shedding 
of R. equi and whether the mare’s foal developed R. equi pneumonia were examined.  
Because there were significant differences observed between years for the concentration 
of R. equi and the proportion of virulent organisms in fecal samples (Table 6; Figures 3, 
5, 7, 9, 11, 12), the data were analyzed separately for 2004 and 2005.  There were, 
however, no significant differences between years in the distribution of the number of an 
individual mare’s samples (up to 4 samples/mare) that were positive for virulent R. equi, 
the prevalence of mares with diseased foals (31% [29/94] in 2004 and 31% [24/77] in 
2005), or the distribution of total scores from ultrasound examinations.  All TBA isolates 
of R. equi obtained from affected foals were confirmed to be R. equi and determined to be 
positive for the vapA gene using a multiplex polymerase chain reaction method.28
 
Association of R. equi in feces with disease status of the foal for mares during 2004 - Of 
the 94 mares included in the study during 2004, 29 mares (31%) had foals that were 
ultimately diagnosed with R. equi pneumonia.  An additional 11 foals had sonographic 
evidence of pulmonary abnormalities but R. equi was not isolated from their TBA fluid; 
β-hemolytic streptococcal organisms were isolated from 7 of these 11 foals and either no 
organisms (2 foals) or presumed contaminants (2 foals) were isolated from the remaining 
foals.  The proportion of foals diagnosed with pneumonia (sonographic and clinical 
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findings indicating a TBA) after June 1, 2004 was significantly (P =0.0003) greater 
among the foals from which R. equi was not isolated from TBA fluid (82%; 9/11) than 
among the foals diagnosed with R. equi pneumonia (17%; 5/29).  Overall, the age at 
diagnosis of pneumonia was significantly (P < 0.0001) greater for foals from which R. 
equi was not isolated (median, 13 weeks; IQ range, 6 to 15 weeks) than for foals from 
which the organism was isolated (median, 6 weeks; IQ range, 5 to 6 weeks).   
There were no significant differences among mares that had foals affected with R. 
equi pneumonia (hereafter referred to as the affected group) and mares whose foals were 
unaffected with R. equi pneumonia (hereafter referred to as the unaffected group) in the 
concentrations of either R. equi or virulent R. equi, or the proportion of virulent R. equi 
(Table 7; Figures 4, 6, 8, 10).  Virulent R. equi were detected in the feces of all mares 
during at least 1 sampling time: 1 (1%) mare was culture-positive for virulent R. equi 
only at 1 sampling time (a mare in the unaffected group), 16 (17%) mares were positive 
for 2 samples, 43 (46%) mares were positive for 3 samples, and 34 (36%) mares were 
positive for all 4 samples.  There was no significant difference between the affected and 
unaffected groups in the distribution of the number of fecal samples in which virulent R. 
equi were detected: 26 mares (90%) in the affected group and 51 (78%) mares in the 
unaffected group were culture-positive in 3 or more samples.   
There were no significant differences between groups for any of the fecal 
outcomes (concentrations of total or virulent R. equi, or proportion of virulent R. equi) 
among the 6 pairs of differences in sampling times (ie, difference 1 = [number for 2 
weeks prior to foaling] – [number for 1 week prior to foaling], difference 2 =  [number 
for 2 weeks prior to foaling] – [number for foaling date], etc.).  Additionally, none of the 
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differences between pairs of sampling times were significantly different, irrespective of 
disease status.  Irrespective of sample (ie, 2 weeks prior to, 1 week prior to, day of, or 1 
week after foaling), there did not appear to be any seasonality in the pattern of shedding 
during 2004 (Figure 1).  There was no significant difference between the concentration of 
either R. equi or virulent R. equi, or the proportion of virulent R. equi in the fecal samples 
of dams at any sampling time among the 3 categories of ultrasound scores.  
 
Association of R. equi in feces with disease status of the foal for mares during 2005 - Of 
the 77 mares included in the study during 2005, 24 mares (31%) had foals that were 
ultimately diagnosed with R. equi pneumonia.  An additional 11 foals had sonographic 
evidence of pulmonary abnormalities but R. equi was not isolated from their TBA fluid; 
β-hemolytic streptococcal organisms were isolated from 5 of these 11 foals and either no 
organisms (1 foal) or presumed contaminants (5 foals) were isolated from the remaining 
foals.  Although the proportion of foals diagnosed with pneumonia (sonographic and 
clinical findings indicating a TBA) after June 1, 2005 was  greater among the foals from 
which R. equi was not isolated from TBA fluid (40%; 4/10) than among the foals 
diagnosed with R. equi pneumonia (21%; 5/24), the difference was not significant.  
Although the age at diagnosis of pneumonia was greater for foals from which R. equi was 
not isolated (median, 8 weeks; IQ range, 5 to 9 weeks) than for foals from which the 
organism was isolated (median, 5 weeks; IQ range, 5 to 6 weeks), the difference was not 
significant (P = 0.0649). 
There were no significant differences among mares in the affected group and 
mares in the unaffected group in the concentrations of either R. equi or virulent R. equi, 
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or the proportion of virulent R. equi (Table 8).  Virulent R. equi were detected in the feces 
of all mares during at least 1 sampling time: 2 (3%) mares were culture-positive for 
virulent R. equi only at 1 sampling time (1 mare each in the affected and unaffected 
groups), 11 (14%) mares were positive for 2 samples, 36 (47%) mares were positive for 3 
samples, and 28 (36%) mares were positive for all 4 samples.  There was no significant 
difference between the affected and unaffected groups in the distribution of the number 
of fecal samples in which virulent R. equi were detected: 21 (91%) of the affected group 
and 43 (80%) of the unaffected group were culture-positive in 3 or more samples.   
There were no significant differences between groups for any of the fecal 
outcomes (concentrations of total or virulent R. equi, or proportion virulent) among the 6 
differences between pairs of sampling times.  Too, none of the differences between 
sampling times were significantly different, irrespective of disease status.  Irrespective of 
sample, there did not appear to be any seasonality in the pattern of shedding during 2005 
(Figure 2).   Significant differences were not detected between the concentration of either 
R. equi or virulent R. equi, or the proportion of virulent R. equi in the fecal samples of 
dams at any sampling time among the 3 categories of ultrasound scores.  
 
Mares with foals born in both years of the study. There were 41 mares that had foals born 
during both 2004 and 2005.  Only 3 of 41 mares had foals affected with R. equi 
pneumonia during both years, whereas there were 8 mares that had affected foals during 
2004 but not 2005, 12 mares with foals affected during 2005 but not 2004, and 18 mares 
with foals that were unaffected in 2004 and 2005.  Thus, there appeared to be no evidence 
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from this study that certain mares were more likely than other mares to have affected 
foals. 
 
Discussion 
Rhodococcus equi is a bacterial pathogen that causes disease in foals worldwide.4  
This bacterium can be isolated from many sources including feces, soil, and TBA fluid.  
Unfortunately, much is still unknown regarding the transmission of R. equi.  The primary 
aim of this study was to determine if dams of affected foals were a potential source of R. 
equi for their foals.  Although disease caused by R. equi is not commonly diagnosed in 
adult horses,2 horses excrete varying fecal concentrations of virulent R. equi into their 
environment.11-13,29,30  Foals exposed to this contaminated environment are thus likely to 
be exposed to virulent R. equi from birth, and epidemiologic evidence indicates that foals 
may be infected during the first few days of life.8   The route of R. equi infection for foals 
is unknown, but is presumed to be by inhalation of organisms from the environment.2  
Because it is common for foals to ingest small quantities of fresh feces passed by their 
dam,17 it is also possible that foals might become infected by coprophagia.  Irrespective 
of the route of infection, results of this study indicate that foals at breeding farms may be 
exposed from the time of birth to virulent R. equi from their dams and other mares.  
An important and novel finding in this study was that virulent isolates of R. equi 
were identified in the feces of all mares tested.  This finding has not been previously 
reported.  Although contamination of specimens either prior to or during collection, or 
after collection in the laboratory, could explain these findings, we do not believe this to 
be the case.  Fecal samples were collected either from the top of a fresh fecal pile (ie, not 
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in contact with the stall) or by manual evacuation from the rectum.  The presence of R. 
equi has been found to be greatest when recovered from the soil surface,12,31 making dust 
during a windy day a potentially contaminating source of the organism.  Therefore, 
contamination of the voided feces cannot be excluded.  Samples were individually 
packaged and shipped in sealed sacks.  In the laboratory, negative and positive control 
plates were used during each culture procedure such that contamination of reagents and 
instruments with virulent R. equi would have been detected.   
Other explanations for the high prevalence of virulent R. equi in fecal specimens 
exist.  Sequential sampling provided increased opportunity to identify R. equi in feces.  
Use of a modified selective NANAT media improved our ability to culture R. equi 
relative to other media, including standard NANAT media (data not shown).  The high 
prevalence of R. equi in feces is consistent with at least 1 previous report from 
Australia.10  To the authors’ knowledge, this is the first report of a method for quantifying 
the concentration of virulent organisms in fecal samples.  Previously, investigations have 
estimated the proportion of virulent isolates in fecal samples by selectively subculturing 
up to 10 colonies selected at random from plates and testing these specimens for 
expression of VapA using immunoblotting.16,22,23  With the modified colony immunoblot 
protocol, placing nitrocellulose membranes directly on the culture plates allowed for 
evaluation of the virulence status of all R. equi isolates on a plate rather than just a 
portion.  Conceivably, the finding of a higher prevalence of mares shedding virulent 
isolates in our study may be a function of improved culture techniques and the use of the 
complete plate colony immunoblot method used.   Interestingly, the proportion of the 
concentrations of virulent isolates in this study was similar in magnitude to the 
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proportions of virulent isolates among isolates subcultured  from fecal samples in 
previous reports.16,22,30,32  Negative and positive control plates were also blotted along 
with the feces culture plates to ensure that the colony immunoblot method was properly 
controlled. 
The concentrations of R. equi cultured from dam feces ranged from >102 to >103 
cfu/g, which is consistent with past reports.22,30,33  Isolation of R. equi from the air had 
previously been reported to increase on dry windy days.31  Furthermore, it has been 
suggested that prevalence of disease appears to increase when climatic conditions are dry 
and dusty.26  No efforts were made in this study to correlate climatic or weather 
conditions with fecal concentrations of R. equi.  Although a previous report documented 
an increase in the isolation of R. equi in feces from breeding mares at the end of March,12 
no apparent seasonality of shedding or temporal variation of fecal concentrations of R. 
equi among breeding mares was observed during the months of the year in which this 
study was conducted (January through June). 
There are a number of limitations of this study.  Results of this study were 
obtained from 1 farm: it is unclear to what extent these results would be similar among 
other farms affected recurrently with R. equi foal pneumonia.  Additionally, it would be 
interesting to know if the prevalence and concentration of fecal excretion of virulent R. 
equi varies among farms affected with R. equi foal pneumonia and unaffected farms.  
Results of such studies would help elucidate the association between R. equi shed in the 
feces of mares at breeding farms and the R. equi pneumonia status of foals at those farms. 
Not all mares contributed 4 samples to the study.  Because foaling dates were 
estimated on the basis of the last breeding date, some mares foaled earlier than expected 
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such that samples were not collected from all mares at each sampling time.  In other 
instances, samples were not collected on the day of foaling or 1 week after because of 
absence of the technician responsible for collecting specimens.  The impact of missed 
sampling was minimal in light of the fact that > 95% of potential samples were collected, 
and the finding that all mares were observed to shed virulent R. equi in feces.   
Another limitation of this study was the possible misclassification of foals.  Only 
foals from which R. equi was isolated from their TBA were classified as having R. equi 
pneumonia.  Although the sensitivity of microbiologic culture is generally high (57-
100%),24,34-39 false-negative results may occur.  Among foals confirmed by necropsy to 
have R. equi pneumonia, TBA has been reported to be 100% sensitive;34,35  however, it is 
sometimes difficult to isolate R. equi from the TBA fluid of experimentally infected 
foals.40 Conceivably, false-negative results might be more likely during the early stages 
of disease.  Because foals included in the study were systematically screened for early 
detection of disease, pneumonia was detected during the early stages for foals in this 
study.  In this study, approximately 28% of foals were culture-negative for R. equi from 
TBA fluid despite sonographic findings of pulmonary lesions.  In some of these cases, R. 
equi was most likely not the cause of the associated lung lesions, particularly when β-
hemolytic streptococcal organisms were isolated from the TBA fluid.41  However, it is 
also possible that some foals with sonographic lesions but from which R. equi was not 
isolated were truly infected with R. equi but the culture results of TBA were falsely 
negative.  To assess the potential impact on results of this misclassification, data were 
analyzed such that all foals with clinical and sonographic evidence of pneumonia 
(irrespective of results of microbiologic culture of TBA fluid) were considered as being 
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affected with R. equi pneumonia: results of these analyses yielded similar results to those 
reported here.  Thus, misclassification of foals with false-negative TBA results did not 
appear to bias the results of this study.  Moreover, the finding that foals undergoing TBA 
from which R. equi was not isolated were either significantly (for 2004) or more likely to 
be (for 2005) older and diagnosed later in the year is consistent with these foals being 
appropriately classified as different from those from which R. equi was isolated 
Analyses were also conducted using the ultrasound scores as a possible indicator 
of severity (ie, were foals with more extensive sonographic lesions from dams with 
higher fecal concentrations or proportions of virulent R. equi than foals with less severe 
lesions?).  No significant association was identified between the category of ultrasound 
severity score and the mare’s group (affected versus unaffected).   
Upon arrival, fecal specimens collected in 2004 were immediately frozen at  
-20ºC.  It was speculated that there would be a loss in the numbers of R. equi if the feces 
were frozen prior to being cultured, but the rate of that loss was unknown.  
Experimentally, we determined that freezing of fecal specimens at -20°C resulted in 
approximately a 0.5 log10 to 1 log10 reduction in growth of R. equi.o  To avoid the 
reduction in numbers resulting from freezing, the 2005 samples were cultured upon 
arrival.  A larger number of contaminants were observed during microbiologic culture of 
the 2005 samples relative to samples from 2004, which was considered likely to be an 
effect of samples having not been frozen prior to culture.  Although the freezing reduced 
the growth of R. equi, it also reduced the growth of contaminants.   
On the basis of a previous report, 31 the dilution containing between 15 and 150 R. 
equi colonies was used for quantitative culture and immunoblotting.  Since fewer than 15 
22 
R. equi colonies were occasionally isolated from a specimen, continuous variables, such 
as the proportion of virulent isolates, included some outliers.  This was more of an issue 
with the data from 2004, because they were frozen at -20°C and the resultant fecal 
concentrations of R. equi were lower.  The Wilcoxon rank-sum and the Kruskal-Wallis 
tests were used for analyses because they are less sensitive to the effects of outliers and 
the non-Gaussian distribution of data.  Analysis of the data following logarithmic or other 
transformations to render them more Gaussian in distribution did not alter results of this 
study.  Nevertheless, the fact that the denominator for calculating the proportion of 
virulent organism was generally smaller in 2004 meant that these proportions were more 
sensitive to the presence or absence of a given colony (ie, the difference between 4 and 5 
colonies being immunoblot-positive was more influential on the estimated proportion of 
virulent organisms when the denominator was 15 than when it was 100).  It is probable 
that the significant difference between years in the proportion of virulent isolates was 
attributable to the fact that there were more plates with small total numbers of R. equi 
colonies enumerated in 2004 than in 2005.  Alternatively, it is possible that virulent 
isolates were less affected by freezing at -20oC than were avirulent isolates.  To the 
authors’ knowledge, experimental evidence to support this hypothesis is lacking.     
The comparisons between years of the concentrations and proportions of R. equi 
assumed independence of samples and ignored the fact that some samples were correlated 
(ie, some mares contributed samples to both years).  We believe the impact of this 
assumption is minimal for the following reasons.  Nearly all samples from a given mare 
at a given time-point had lower concentrations for 2004 than for 2005 (data not shown).  
Ignoring the correlation in the data meant that we underestimated the variance of the data 
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used for significance testing.  Although we may have overestimated the number of 
significant differences or the magnitude of significance of these differences, the fact that 
samples were processed differently between years and that exploratory data analysis 
between years supported our approach of analyzing data separately from each of the 2 
years.  Although it does not speak directly to this issue, the magnitudes of the P values 
for the between-year comparisons were all adjusted (inflated) for the 12 comparisons that 
were made. 
 The fact that all samples were not collected by manual evacuation from the 
rectum raises the possibility that samples included in the study were contaminated by the 
environment.  Although some fecal samples were collected by manual rectal evacuation, 
the majority were collected from the stall.  Although samples were collected fresh and 
from the top of piles to avoid contact with bedding, etc., it is possible that specimens 
were contaminated by isolates of R. equi that were either air-borne or in bedding.   
The motivation for this study was to determine whether mares were a possible 
source of infection for their foals; however, exposure of foals to virulent R. equi was not 
directly assessed in this study.  Serologic assessment of exposure to virulent R. equi in 
foals is problematic because of poor sensitivity and specificity.42,43  Using the methods 
described in this study to evaluate fecal specimens might yield evidence of exposure to 
virulent R. equi.   Such monitoring was beyond the scope of this study 
Results of this study are important because they indicate that all mares at a 
breeding farm with recurrent R. equi foal pneumonia were shedding virulent R. equi in 
feces during the perinatal period: these virulent isolates are a potential source of infection 
for susceptible foals.  It would be important to substantiate these findings at other farms, 
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and to compare findings of fecal concentrations of R. equi among mares from farms with 
recurrent R. equi pneumonia and farms without such history.  The method of quantifying 
the concentration of virulent R. equi in fecal or other specimens (such as soil or tissue) 
may be useful to other investigators.   
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CHAPTER III 
 
CONCLUSIONS AND DISCUSSION 
 
 
 In addition to the work described in Chapter II, a number of other experiments 
were conducted for this project.  The principal objective of this chapter is to summarize 
that work. 
 
Foal Fecal Specimens 
Fecal specimens were collected from 171 foals on the day of foaling and 1 week 
post-foaling over a 2-year period.  Originally, the foal feces were going to be analyzed 
for the study but because the majority of the fecal samples collected came in the form of 
swabs taken from the foals’ rectums, the concentration of R. equi in feces could not be 
quantified.  Since quantification was not possible, determining if the foal was shedding R. 
equi and virulent R. equi in its feces became the focus for these samples.  A swab was 
cultured by directly plating it onto the surface of each of 2 NANAT agar plates (duplicate 
to maximize growth potential).  Inoculated plates were allowed to incubate at 34ºC for 48 
hr.  Culturing rectal swabs was not an ideal method for determining if foals were 
shedding R. equi in their feces because of the small amount of fecal material and viable 
organisms present on the swabs.  Swabs typically grew only a small amount of R. equi, 
which may or may not be representative of the number of R. equi excreted in feces by a 
particular foal.  Enrichment of the fecal swabs using a modified NANAT medium broth 
for 24 hr at 34ºC was attempted, but was unsuccessful at minimizing other bacterial 
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growth.  Since R. equi grows relatively slowly compared to other organisms, enrichment 
allowed for fecal contaminants to flourish and mask the R. equi growth.  
Two methods were proposed to determine whether or not the foals that were 
shedding R. equi in their feces were shedding virulent R. equi: (1) Up to 10 colonies were 
picked (placing in same tube) from the duplicate culture plates, DNA was then extracted 
using the alkaline lysis procedure described below, and a real-time polymerase chain 
reaction (RT-PCR) assay44 was performed for confirmation of the presence or absence of 
the vapA gene; and, (2) 2 NANAT agar plates were inoculated with swabs and the plates 
were tested for virulence by using the colony-blot technique.  Since the proportion of 
fecal isolates of R. equi that were virulent was 14% in a previous report,30 these methods 
were consistently unsuccessful, presumably because all swabs from 2004 were frozen at  
-20°C and freezing greatly reduced the viability of R. equi.  There were low numbers of 
total R. equi grown from the swabs, and low proportions of virulent isolates determined, 
meaning that false-negatives were probable.  In 2005, the swabs were cultured upon 
arrival and not frozen, but culture was unsuccessful because of the limited amount of 
fecal material present on the swabs.  Varying amounts of data were accumulated from 
both of these methods, as summarized in Appendix A (Tables 13-17).   
Swabs were cultured using NANAT agar medium during both years.  The colony-
blot technique was used in 2004 to determine virulence status of the limited numbers of 
R. equi grown.  Both colony-blot and RT-PCR of DNA extracted using the alkaline lysis 
procedure of R. equi colonies were used to detect virulent isolates from the 2005 swabs.  
RT-PCR was not used on the 2004 swabs because of contamination of samples that 
occurred during extraction during that time. 
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In 2005, there was poor correlation between the 2 methods of determining 
virulence when performed on colonies from the same sample swab.  Results of foal fecal 
data are summarized in Tables 9 through 17 (Appendix A); these data were not submitted 
for publication because of difficulties with their interpretation resulting from the 
aforementioned problems.  
 
Morphology Assessment Experiments 
Before mare and foal fecal samples were processed, studies were conducted to 
become familiar with the identification and growth characteristics of R. equi, and to 
confirm that the use of the NANAT agar medium did not inhibit its growth.  These 
experiments involved using the virulent (ATCC 33701+) and avirulent (ATCC 33701-) 
strains of R. equi in minimal media,18 referred to as pure culture.  Serial dilutions of 
virulent and avirulent R. equi in pure culture were plated onto modified NANAT agar 
medium, counted, and cfu/ml determined in order to characterize accuracy of these 
procedures.  Horse feces from Texas that were previously culture-negative for R. equi 
were also inoculated with these bacterial dilutions, plated, counted and the cfu/g 
calculated.  These studies were important to perform because of the wide range of 
bacterial and fungal contaminants present in feces.  Even using a modified NANAT 
media, these contaminants were not fully suppressed.  Recognizing R. equi and 
understanding its morphology were vital for assessment during all projects.  Colonies of 
R. equi appear to vary in size (2-4 mm), be irregularly round, smooth, semitransparent, 
glistening, and mucoid.45  
 
28 
Media Experimentation 
Experimental analyses of several different types of agar media used to identify R. 
equi were performed. CAZ-NB containing ceftazidimedd, novobiocin and cycloheximide 
is a medium that had been used by other researchers and its ability to reliably culture R. 
equi had been tested.46  The original NANAT agar medium was described as the most 
accurate agar medium for isolating R. equi.10  Both were prepared in the laboratory and 
virulent (ATCC 33701+) and plasmid-cured (ATCC 33701-, avirulent) R. equi in 
minimal media18 were used to determine possible inhibitory effects on growth of R. equi.  
The virulent and avirulent strains of R. equi were simultaneously cultured onto trypticase 
soy agar with 5% sheep red blood cells (RBC),ee (BAM) as a base of comparison since 
BAM is not inhibitory to R. equi.  Amphotericin B,ff a common antifungal,47 was added 
to the CAZ-NB agar at the manufacturers recommendation of 5.6 mg/l to help reduce 
fungal growth.  Approximately 108 cfu/ml of R. equi (both virulent and avirulent, 
independently) were used to perform serial dilutions (1:10).  The dilution containing 
approximately 102 cfu/ml of R. equi was inoculated onto the various types of agar plates, 
in duplicate.  Results after the inoculated agar plates were allowed to incubate at 34ºC for 
48 hr are summarized in Table 1. 
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Table 1. BAM vs. CAZ-NB and NANAT agar media 
Agar Medium ATCC 33701+ ATCC 33701- 
BAM 3.2 x 108 3.0 x 108
CAZ-NB 5.0 x 107 7.0 x 107
CAZ-NB + Amp B 4.2 x 107 3.4 x 107
NANAT 0 0 
 
It was determined that both the CAZ-NB and NANAT agar media inhibited the 
growth of R. equi.  It is likely that the failure to grow any R. equi on the initial NANAT 
agar medium was a result of a mistake made while making the medium or some kind of 
experimental error.  Before further experimentation was performed, we became familiar 
with a proven modified version of the NANAT agar medium and decided to test it, rather 
than resuming efforts to succeed with the standard NANAT. 
An experiment was performed upon receipt of the recipe for the modified 
NANAT agar medium, generously provided by Dr. Shinji Takai, for confirmation that it 
would not inhibit growth of R. equi.  Using both virulent and avirulent R. equi, grown to 
approximately 108 cfu/ml in minimal media,18 10-fold serial dilutions were performed 
with PBS.  The dilution containing approximately 102 cfu/ml of R. equi was plated, using 
100 µl, onto the modified NANAT agar medium and BAM, in duplicate.  Agar plates 
were placed at 34ºC for 48 hr.  Following incubation, the plates were removed and 
counted; results from this experiment are summarized in Table 2.  It was determined that 
the modified NANAT agar medium did not inhibit the growth of R. equi grown in 
minimal media. 
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Table 2. BAM vs. modified NANAT agar medium with R. equi in pure culture and 
inoculated feces 
Agar Medium ATCC 33701+ ATCC 33703- 
BAM (PC) 2.5 x 108 3.0 x 108
Modified NANAT 
(PC) 
3.3 x 108 2.7 x 108
Modified NANAT 
(feces) 
2.0 x 108 2.5 x 108
 
Experimental analysis of the modified NANAT agar medium was also performed 
using equine feces that had been inoculated with similar amounts of virulent or avirulent 
R. equi grown in minimal media.18  Since BAM is not selective and is beneficial for 
growth of all organisms that are present in a specimen, only the modified NANAT agar 
medium was used for this experiment.  Fecal material (previously culture-negative for R. 
equi) was weighed into 3-g aliquots and approximately 108 cfu of virulent or avirulent R. 
equi in minimal media was added to the feces.  The same virulent and avirulent R. equi in 
minimal media that were used for plating the pure culture portion of the experiment were 
used to inoculate the feces.  Ten-fold serial dilutions were performed using PBS and 100 
µl, which contained about 102 cfu of R. equi, and each dilution was plated in duplicate.  
Modified NANAT agar plates were allowed to incubate for 48 hr at 34ºC before being 
removed and counted.  After the colonies were counted it was determined that the 
modified NANAT agar medium did not significantly inhibit the growth of R. equi in 
equine feces (Table 2).  The feces were originally inoculated with 108 cfu of R. equi, 
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meaning that inhibition was not observed with the modified NANAT agar medium.  The 
subtle difference in the cfu’s counted on the modified NANAT agar plates between 
inoculated feces and pure culture (Table 2) could have been due to a pipetting error or to 
the feces being slightly inhibitory to the bacterium.  Regardless, the modified NANAT 
agar medium was determined to be the best medium for culturing R. equi.  
 
Effect of Duration on Freezing Fecal Specimens 
 Prior to acquiring funding for the feces project, fecal specimens from participating 
mares in the 2004 sampling period were collected and frozen at -20ºC upon arrival.  It 
was speculated that freezing fecal specimens at -20ºC would have an effect on the 
amount of R. equi isolated.  Experimentally, it was determined that between a 0.5 log10 to 
a 1 log10 reduction occurred due to freezing the specimens at -20ºC.  No apparent 
difference between fresh and frozen samples was observed when fecal specimens were 
experimentally frozen at -80ºC, meaning that this would have been the better choice.  
Due to limitations of time and personnel, the experiment could not be performed prior to 
sample collection.  Data from the relevant experiment are summarized in Table 3.  Feces 
aliquoted in 1.5-g increments in multiple tubes were inoculated with approximately 108 
cfu of virulent R. equi.  One R. equi inoculated tube was immediately cultured onto 
modified NANAT agar medium, in duplicate, to serve as the control (baseline) value for 
comparison with frozen specimens; the control is described in Table 3 as the “fresh” 
sample.  The remaining aliquots were then either frozen at -20ºC or -80ºC.  Inoculated 
feces were then removed from the freezers in 1-week increments for 4 weeks to 
32 
determine if length of time frozen had any effect on the viable R. equi.  The method for 
culturing was identical to the method used in Chapter II for the mare fecal specimens. 
 
Table 3. Effects of freezing feces inoculated with virulent R. equi at different lengths of 
time and temperatures    
Time Frozen (weeks) -20ºC Freezer -80ºC Freezer 
1 1.0 x 108 cfu/g 1.8 x 108 cfu/g 
2 2.8 x 107 cfu/g 1.5 x 108 cfu/g 
3 2.6 x 107 cfu/g 1.4 x 108 cfu/g 
4 2.7 x 107 cfu/g 1.8 x 108 cfu/g 
“Fresh” inoculated fecal specimen contained 2.1 x 108 cfu/g 
 
 
Effect of Thawing and Duration on Freezing Fecal Specimens 
 After the initial experimentation that was described above was completed, it was 
important to determine the probable detrimental effects of freezing samples and thawing 
them on multiple occasions.  To examine the effects of thawing and duration, 1.5-g fecal 
samples were again aliquoted and inoculated with approximately 108 cfu of R. equi.  For 
this experiment, both a virulent (ATCC 33701+) and an avirulent (ATCC 33701-) strain 
of R. equi were used.  By using both virulent and avirulent R. equi it was possible to 
evaluate whether one biotype of R. equi was affected more than the other by thawing and 
duration of freezing at -20ºC and -80ºC.  One virulent and one avirulent R. equi-
inoculated tube were immediately cultured onto separate modified NANAT agar medium 
plates, in duplicate, to serve as the control values for comparison with frozen specimens; 
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these controls are described in Table 4 as the “fresh” samples.  Each week, all sample 
tubes were removed from the freezer and allowed to thaw at room temperature for 45 
min.  After documenting that fecal specimens had thawed, the tubes that were not used 
for culture were placed back into the appropriate freezer.  The number of weeks in Table 
4 also represents the number of times that the sample was thawed. 
 
Table 4. Effects of freezing feces inoculated with virulent or avirulent R. equi at different 
lengths of time, temperatures, and number of times thawed 
 ATCC 33701+ ATCC 33701- 
 -20ºC -80ºC -20ºC -80ºC 
1 week 1.33 x 107 cfu/g 1.93 x 108 cfu/g 2.60 x 106 cfu/g 1.83 x 108 cfu/g
2 weeks 1.85 x 106 cfu/g 1.20 x 108 cfu/g 1.02 x 106 cfu g 9.33 x 107 cfu/g
3 weeks 8.67 x 105 cfu/g 8.50 x 107 cfu/g 5.00 x 104 cfu/g 2.63 x 107cfu/g 
4 weeks 1.22 x 105 cfu/g 8.33 x 107 cfu/g 2.42 x 102 cfu/g 9.50 x 106 cfu/g
“Fresh” inoculated fecal specimen with ATCC 33701+ contained 2.33 x 108 cfu/g 
“Fresh” inoculated fecal specimen with ATCC 33701- contained 2.43 x 108 cfu/g. 
 
From this study, it appeared that both the virulent and plasmid-cured (avirulent) R. equi 
could be dramatically affected by continuous thawing and freezing at -20ºC.  The 
avirulent R. equi appeared to have greater loss when compared to the virulent R. equi at 
this temperature.  These fecal specimens were experimentally inoculated with 108 cfu, but 
in the fecal study described in Chapter II, the average total concentrations of R. equi were 
much smaller (102-103 cfu/g).  Multiple thawing in a farm-based study could be 
detrimental to the outcome.  It also appears from the results that freezing at -80ºC, 
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regardless of the number of times thawed always yielded less loss than that of the -20ºC.  
This experiment needs to be repeated to ensure the validity and repeatability of the 
results.  Also, it would be interesting to examine the effects of freezing and thawing on 
soil samples, because of the epidemiologic importance of studies of the concentration and 
proportion of virulent R. equi in soil of affected and unaffected farms. 
 
 
Colony Immunoblotting Substrate and Membrane Experimentation 
Trial experiments using the virulent and avirulent strains of R. equi (ATCC 
33701+ and 33701-, respectively) blotted onto nitrocellulose membranes from modified 
NANAT agar plates were performed to ensure the validity of the colony-blot method.  
Problems arose when using several substates toward the end of the protocol.  The 
substrate is designed to bind to the colonies previously selected by the secondary 
antibody, causing a color change in the virulent R. equi.   
Three different substrates were tried along with 3 different types of membranes in 
order to obtain the best results from blotting fecal culture plates.  The substrates tested 
were Western Bluegg-stabilized substrate for alkaline phosphatase, 3,5’-diaminobenzoic 
acidhh (DAB), and TMB.  The Western Blue-stabilized substrate for alkaline phosphatase 
was unsuccessful for differentiating between virulent and avirulent R. equi.  Alkaline 
phosphatase was present in both virulent and avirulent strains of R. equi.  This finding 
was not surprising because alkaline phosphatase activity is also found in many other 
bacteria.  The next substrate, DAB, was also tested by using the aforementioned virulent 
and avirulent strains of R. equi.  This substrate never gave a positive reaction with either 
virulent ATCC 33701+ or avirulent ATCC 33701-.  TMB, which was a substrate that had 
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previously been compared to DAB,48 was successful for identifying the virulent strain of 
R. equi.  It was tested thoroughly using both virulent and avirulent R. equi in minimal 
media to ensure the validity and repeatability of the results.  
Nylonii, polyvinylidene difluoridejj (PVDF), and nitrocellulose membranes were 
tested to identify the best membrane for colony-blotting fecal culture plates.  Nylon and 
nitrocellulose membranes both were considered efficient when blotting fecal culture 
plates inoculated with virulent and avirulent R. equi.  The PVDF membranes did not 
work well for reasons unknown.  All 3 of these types of membranes are used successfully 
for protein blotting.49  Nylon membranes came in the form of sheets, while the 
nitrocellulose membranes were in a roll.  Due to the packaging of the nylon membranes 
from the manufacturer, nitrocellulose membranes were selected because economically 
they were considered a better value and had been used during the substrate experiments.  
 
Validation of the Colony Immunoblot Assay 
 The colony-blot method was modified from its original protocol19 a number of 
times before achieving a working state.  There were several experiments that were 
performed to validate the method.  Colony-picking, which had been done numerous times 
in past reports,16,22,23 was done using both virulent and avirulent strains of R. equi grown 
onto the modified NANAT agar medium from minimal media.18  Plates were inoculated 
with approximately 102 cfu/ml of virulent and avirulent R. equi, separately.  These plates 
were allowed to incubate at 34ºC for 48 hr. Using a toothpick, individual colonies (10 
total) were then picked off of each type of plate and placed onto separate nitrocellulose 
membranes.  Membranes were then subjected to the full colony-blot protocol.  Using this 
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technique, the membrane that contained the virulent R. equi colonies had a color change 
and all 10 colonies picked from the modified NANAT agar plates were visible.  The 
membrane which contained the avirulent strain of R. equi was blank, with no color 
change observed.  
 After having success with the colony-picking experiment, it was necessary to test 
the possibility of placing the nitrocellulose membrane onto the surface of the modified 
NANAT agar plate and blotting all the R. equi colonies from the plate’s surface onto the 
membrane.  This was again performed using separate plates containing either virulent or 
avirulent R. equi grown from minimal media.18  Feces inoculated with approximately 102 
cfu/g of both strains of R. equi were plated separately onto the modified NANAT for use 
in this experiment.  Nitrocellulose membranes, cut to fit the circular plate, were carefully 
placed onto each plate’s surface and allowed to become completely saturated before 
being removed.  The colony-blot protocol was then carried out on these blotted 
membranes and the results were as expected: a positive color change was observed on the 
membrane which contained the virulent R. equi grown from minimal media and on the 
membrane that contained the virulent R. equi grown in feces; a color change was not 
observed on the membrane containing avirulent R. equi grown from minimal media or on 
the membrane that contained the avirulent R. equi grown in feces.  On the plates that 
contained either strain of R. equi from feces, there was “background” observed.  This 
background was not the blue color associated with virulent R. equi, but appeared to 
represent bacteria other than virulent R. equi that were grey in color and that yielded a 
non-specific reaction with the reagents (Figure 13).  It might be possible that the 
background that is being observed could be due to other bacteria expressing VapA.  
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VapA is one of a cluster of genes encoded by a pathogenicity island.  Pathogenicity 
islands are thought to be genes derived from other organisms.  Many types of bacteria are 
present in the intestinal tract of horses.  Because they share an environment with R. equi, 
it is possible that the pathogenicity island encoding VapA is possessed by other 
organisms in the intestinal environment. 
 The 2 experiments carried out above were used to validate the colony-blot 
method.  One other experiment was carried out in an attempt to colony-blot NANAT agar 
plates containing known proportions of both virulent and avirulent R. equi in feces and 
minimal media and to verify the colony-blot results by amplifying the vapA gene using 
PCR.28  Modified NANAT agar plates were inoculated with equal proportions (1:1) of 
pure culture of virulent ATCC 33701+ and avirulent ATCC 33701- (102 cfu/ml) of each.  
The same proportions of the virulent and avirulent R. equi were also added to 1-g of 
feces, which was plated.  Plates were allowed to incubate at 34ºC for 48 hr before being 
removed and assessed.  There were 14 R. equi colonies that were counted from the 
inoculated feces plate and 29 R. equi colonies from the pure culture plate.  Diagrams 
were drawn of the plates and the locations of individual colonies were noted. Using 
disposable sterile loops, half of each colony was placed into 3 ml of modified NANAT 
broth and prepared for enrichment.  The remaining half colonies were immunoblotted by 
placing a nitrocellulose membrane over the top of the agar plate and following the 
modified protocol.  After enriching the half colonies for 24 hr at 34ºC, DNA was 
extracted from 1.5 ml of the enriched broth using the alkaline lysis method.  Muliplex 
PCR28 was performed on the extracted enrichment broth and the results are summarized 
in Table 5. 
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Table 5. Colony-blot and PCR results from equal proportion of virulent and avirulent R. 
equi 
 PCR + PCR- TOTAL 
Colony-blot + 7 12 19 
Colony-blot - 5 19 24 
TOTAL 12 31 43 
 
The results from this experiment should have shown that the colonies that were PCR-
positive were also colony-blot-positive and vice versa.  This, however, was not the case.  
There are a number of possible explanations for this unexpected discrepancy of results 
between methods for identifying vapA.  It is possible that there were PCR inhibitors in 
extracted DNA from the modified NANAT enrichment broth.  Alternatively, removing 
half of each colony could have left too little residual antigen to detect with colony 
blotting.  False-positive results of PCR might have occurred as a result of DNA 
contamination during the extraction or amplification phases.     
 
Extraction of DNA from Horse Feces 
Prior to the development of a modified colony immunoblot protocol, in an attempt 
to quantify virulent R. equi using RT-PCR, DNA extraction of equine feces was 
attempted using many variations to the original protocol50,51 but without success.  DNA 
recovered from the feces of mares collected at different sampling times both pre- and 
post-foaling was to be quantitatively assessed for virulent R. equi by extracting the DNA 
and using a RT-PCR assay44 to detect VapA.  Although success of extracting DNA from 
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feces of horses from Kentucky never occurred, there were some successes using a 
modified protocol when feces of horses from Texas were inoculated with the virulent and 
avirulent strains of R. equi and extracted using the identical protocol. 
 It was never determined what specifically was causing the difficulty in extracting 
DNA, but it was speculated that there were PCR inhibitors in the feces of mares from 
Kentucky that inhibited amplification.  Polyphenolic substances present in plant tissues 
are considered highly inhibitory to PCR.52  Bile salts, hemoglobin degradation products, 
and complex polysaccharides are commonly associated with human feces53,54 and may to 
some extent extend to horse feces.  It was speculated that differences in diet between 
Texas and Kentucky horses probably caused the RT-PCR inhibition of the extracted 
DNA (e.g., feed additives such as mycotoxin binders).  
The protocol used in the attempt to accurately extract DNA from feces of both 
Texas and Kentucky horses was as follows: One g of fecal matter was incubated 
overnight at 4°C in 5 ml 1XTE (1 M tris-HClkk pH=8.0, 0.5 M EDTA pH=8.0, ddH2O) 
containing 0.5% Triton-X.ll  The supernatant was transferred to a 2 ml microcentrifuge 
tube, making sure the fecal pellet was left undisturbed.  The supernatant was 
centrifugedmm at 14,000 rpm (16,000 x g) for 20 min.  The supernatant was removed and 
discarded while the bacterial pellet was mixed with the following: 45 µl 5 M NaCl; 200 
µl lysing solution (50 mM EDTA, 50 mM tris HCl, 20% sucrosenn in ddH2O); 36 µl 10% 
hexadecyltrimethylammonium bromideoo (CTAB)/0.7 M NaCl; 6.6 µl 10% β-
mercaptoethanol.pp  The tube containing the bacterial pellet was then vortexed in order to 
loosen it from the bottom.  Using a transfer pipette, the entire contents of the 
microcentrifuge tube was transferred into a lysing matrix b tubeqq (bead beater tube). 
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Using a specialized lysing matrix instrument called FastPrep®rr, the tube was beat at 
speed 6 for 40 sec.  After beating, the following was added to the bead beater tube: 166µl 
5 M NaCl; 1 ml lysing buffer [100 mM NaCl, 25 mM EDTA, 10 mM tris HCl and 0.5% 
sodium dodecyl sulfatess (SDS)]; 5 µl 20 mg/ml proteinase Ktt; 134 µl 10% CTAB/0.7 M 
NaCl; and 40 µl 10% β-mercaptoethanol.  The fluids that were added to the bead beater 
tube in this step aided in getting all the beated material out of the bead beater tube and 
into a new sterile 2 ml microcentrifuge tube.  Without this addition, the fluid appeared 
very sticky and a severe loss of DNA was likely.  The bead beater tube was quickly 
centrifuged so that material was not left on the side of the tube.  The supernatant was then 
transferred back into a 2 ml microcentrifuge tube.  The tube was vortexed and incubated 
at 60°C for 60 min.  Upon completion the tube was vortexed and incubated at 65°C for 
10 min.  An equal volume of chloroformuu was added to the microcentrifuge tubes and 
shaken for 5 min.  It was important to make sure that the tube was closed tightly to 
prevent DNA loss.  The microcentrifuge tube was centrifuged at 13,000 rpm (14,000 x g) 
for 5 min before the aqueous layer was transferred to another sterile 2 ml microcentrifuge 
tube.  One-tenth of the total volume of 10% CTAB/0.7 M NaCl was added into the new 
microcentrifuge tube.  It was vortexed and incubated at 65°C for 10 min.  An equal 
volume of chloroform was next added and shaken for 5 min.  The tube was again 
centrifuged at 13,000 rpm (14,000 x g) for 5 min before the aqueous layer was transferred 
to new tube.  An equal volume of phenyl/chloroform/isoamylvv (PCI) was added and 
shaken for 5 min.  For 5 min at 13,000 rpm (14,000 x g) the tube was centrifuged and the 
aqueous layer was transferred.  The PCI extraction was repeated twice.  An equal volume 
chloroform extraction was performed once more.  One-fifth of the total volume of 10 M 
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Ammonium acetateww was added to the previous aqueous layer and mixed by inverting 
the tube.  An equal volume of isopropanol was added and again the tube was inverted.  
The extraction was allowed to centrifuge for 20 min at 13,000 rpm (14,000 x g) before 
the liquid was removed.  An equal volume of 70% ethanol was added and the tube was 
vortexed until the pellet was dislodged from the bottom of the tube.  The tube was 
centrifuged for 10 min at 13,000 rpm (14,000 x g) before the ethanol was removed.  
Using a SpeedVac,xx vaccum the DNA pellet was dried.  The DNA pellet was 
resuspended using 25 µl 1XTE, pH 8.0.  Resuspended DNA was placed in a 50°C water 
bath for 20 min in order to get the pellet to dissolve completely before freezing.  The 
DNA was stored at -80°C. 
A number of steps, after extracting the DNA from Kentucky feces, were also tried 
to attempt to purify the DNA pellet.  Kits such as GenSpinyy and Puregenezz were used 
with no success.  DNA Bind,55 a solution made that had been previously used50 was 
unsuccessful at removing the PCR inhibitors present in the fecal DNA.  Magnetic beads 
were attempted by using a ChargeSwitch® gDNA kitaaa specialized for blood.  The idea 
behind the magnetic bead method was to place the DNA in contact with the beads.  The 
DNA automatically adheres to the beads in a low pH environment due to the positive 
charge of the bead and the negatively charged nucleic acid backbone.  Washing the 
inhibitors from the DNA was possible after it became securely stuck to the beads.  
Proteins and other contaminants do not adhere and were washed away.  All of these 
protocols were unsuccessful in purifying extracted DNA for detection by RT-PCR. 
Lysozymebbb was first used to lyse the gram-positive R. equi but proteinase K was 
thought to be more successful.  Using lysozyme also added to the length of the protocol 
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because it required an extra incubation at 37ºC for 30 min.  The proteinase K appeared to 
be sufficient when feces from Texas spiked with virulent ATCC 33701+ and avirulent 
ATCC 33701– were extracted. 
 
Extraction of DNA from Pure Culture, TBA Fluid, and Isolated Colonies 
The extraction of DNA from pure culture, TBA fluid, and isolated colonies was 
performed by the use of a modified alkaline lysis procedure56  Depending on the type of 
sample from which DNA was extracted (isolated colonies, pure culture, or TBA fluid) the 
first 2 steps differed slightly.  When extracting from isolated colonies, single colonies 
were picked from an agar plate with a sterile loop.  Colonies were placed in 1 ml of PBS, 
and vortexed until the bacteria were thoroughly distributed with no clumps present.  
When extracting DNA from pure culture or TBA fluid, the protocol described below was 
used. 
Samples were centrifuged at 10,000 rpm (8,500 x g) for 10 min in order to pellet 
the cells.  The supernatant was decanted without disturbing the pellet, and then 300 µl of 
TENS (0.1 M NaOH,ccc 10 ml 10XTE, 25 ml 20% SDS) was added to the tube containing 
the pellet.  The sample was vortexed briefly and incubated at room temperature for 10 
min.  After the sample has incubated for 10 min at room temperature, the sample was 
placed directly on ice.  Then 150 µl of 3 N sodium acetateddd pH 5.2 was added and 
vortexed briefly.  Samples were centrifuged for 2 min at 14,000 rpm (16,000 x g) and 
17°C.  The supernatant was transferred to a sterile 1.5-ml microcentrifuge tube.  To the 
supernatant, 10 µl poly acryl carriereee (PAC) was added and this was inverted gently.  
One ml of room temperature 100% isopropanol was added and again inverted gently to 
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thoroughly mix.  The sample was centrifuged for 20 min at 14,000 rpm (16,000 x g) and 
17°C.  Isopropanol was then removed without disturbing the DNA pellet.  The DNA 
pellet was washed with 1 ml of ice cold ethanol, and vortexed until the pellet was 
dislodged from the bottom of the tube.  Samples were centrifuged for 10 min at 14,000 
rpm (16,000 x g) and 4°C.  Ethanol was then removed without disturbing the DNA pellet, 
and the pellet was vacuum-dried and resuspended in 25 µl 1XTE, pH 8.0.  DNA was 
stored at -80°C until use.  It was sometimes useful to place resuspended DNA in a 50°C 
water bath for 20 min in order to get the pellet to dissolve completely before freezing. 
 
Soil Study 
Quantitative culturing of soil from affected and unaffected farms in Kentucky was 
performed to determine the total concentrations of R. equi, and colony-blotting of the 
culture plates was conducted to determine the proportion of virulent R. equi present in a 
given sample.  The primary aim of this particular study was to determine if an association 
existed between the number of virulent organisms cultured from the soil and the current 
R. equi pneumonia status of different affected and unaffected farms. 
 Soil was weighed upon arrival and cultured onto the modified NANAT agar 
medium.  The plates were allowed to incubate at 34°C for 48 hr.  Using the morphologic 
description previously described, plates were counted and the number of cfu/g present 
were calculated.  Nitrocellulose membranes were placed directly on the cultures and the 
colony immunoblotting technique previously described was used to assess the number of 
virulent R. equi isolates present on the plates.  
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 This study is important because the results of the work described in this thesis 
showed no association between individual mares shedding R. equi in their feces and the 
disease status of their specific foals.  Thus, revisiting the role of the soil in the 
environment that the foals are placed in after birth as a potential source of infection 
seemed logical.  Results of the work described here indicate that virulent R. equi is in the 
soil of both affected and unaffected farms at varying levels.  There may be an association 
between proportion of virulent R. equi and time of year that the soil sample is collected. 
More sampling times are planned to aid us in evaluating this relationship. 
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ENDNOTES 
 
a Phosphate-buffered saline, pH 7.2, Invitrogen Co, Carlsbad, CA. 
b Peptone from Glycine max (soybean), Type IV, powder, Sigma Chemical Co, St Louis, 
MO. 
c Sodium chloride, ACS reagent, Sigma Chemical Co, St Louis, MO. 
d Yeast extract, Fluka by Sigma Chemical Co, St Louis, MO. 
e D-(+)- Glucose, anhydrous, Sigma Chemical Co, St Louis, MO. 
f Sodium dithionite, >85% (RT), Fluka by Sigma Chemical Co, St Louis, MO. 
g Sodium thiosulfate, 99%, Sigma Chemical Co, St Louis, MO. 
h Potassium phosphate dibasic powder, Sigma Chemical Co, St Louis, MO. 
i Sodium bicarbonate, Sigma Chemical Co, St Louis, MO. 
j Technical agar, Difco by BD Biosciences Co, San Jose, CA. 
k Novobiocin sodium salt minimum 90% HPLC, Sigma Chemical Co, St Louis, MO. 
l Cycloheximide minimum 94% TLC, Sigma Chemical Co, St Louis, MO. 
m Nalidixic acid sodium salt, Sigma Chemical Co, St Louis, MO. 
n Potassium tellurite powder, Sigma Chemical Co, St Louis, MO. 
o Grimm MB. Evaluation of mares as a source of Rhodococcus equi for their foals using 
quantitative culture and a colony immunoblot assay. MS thesis, Department of Large 
Animals Clinical Sciences, Texas A&M University, College Station, TX, 2006. 
p Nitrocellulose membranes (pore size; 0.45µm), Bio-Rad Laboratories, Hercules, CA. 
q Hybridization oven, VWR International, West Chester, PA. 
r Non-fat dry milk, Bio-Rad Laboratories, Hercules, CA. 
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s Tween 20 Solution, Bio-Rad Laboratories, Hercules, CA. 
t Tris-buffered saline, Bio-Rad Laboratories, Hercules, CA. 
u Rocking platform, VWR International, West Chester, PA. 
v Provided by Dr. Shinji Takai, Department of Animal Hygiene, School of Veterinary 
Medicine and Animal Science, Kitasato University, Towada, Aomori, Japan. 
w Horseradish peroxidase-conjugated goat immunoglobulin G fraction to mouse 
immunoglobulin G, MP Biomedicals Inc, Aurora OH. 
x Sodium citrate, Sigma Chemical Co, St Louis, MO. 
y Ethylenediaminetetraacetic acid, Sigma Chemical Co, St Louis, MO. 
z Dextran sulfate, Sigma Chemical Co, St Louis, MO. 
aa 3,3’,5,5’-tetramethylbenzidine, Sigma Chemical Co, St Louis, MO. 
bb Slovis NM, McCracken JL, Mundy G. How to use thoracic ultrasound to screen foals 
for Rhodococcus equi at affected farms (abstr), in Proceedings. Annu Meet Am Assoc 
Equine Pract 2005;274-278. 
cc S-PLUS, Version 7.0, Insightful, Inc., Seattle, Wash. 
dd Ceftazidime, Sigma Chemical Co, St Louis, MO. 
ee Trypticase Soy Agar with 5% sheeps RBC, BBL Prepared Media, Beckton-Dickinson 
Microbiology Sysytems, Cockeysville, MD. 
ff Amphotericin B, Sigma Chemical Co, St Louis, MO. 
gg Western Blue, Promega, Madison, WI. 
hh 3,5’-diaminobenzoic acid, Sigma Chemical Co, St Louis, MO. 
ii Nylon membranes, Bio-Rad Laboratories, Hercules, CA. 
jj Polyvinylidene difluoride membranes, Bio-Rad Laboratories, Hercules, CA. 
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kk Tris-HCl, Bio-Rad Laboratories, Hercules, CA. 
ll Triton-X, Sigma Chemical Co, St Louis, MO. 
mm Microcenrifuge Eppendorf 5417 R, VWR International, West Chester, PA. 
nn Sucrose, Sigma Chemical Co, St Louis, MO. 
oo Hexadecyltrimethylammonium bromide, Sigma Chemical Co, St Louis, MO. 
pp β-mercaptoethanol, Sigma Chemical Co, St Louis, MO. 
qq Lysing Matrix B tubes, Qbiogene, Carlsbad, CA. 
rr FastPrep® Instrument, Qbiogene, Carlsbad, CA. 
ss Sodium dodecyl sulfate, Sigma Chemical Co, St Louis, MO.  
tt Proteinase k, Sigma Chemical Co, St Louis, MO. 
uu Chloroform, EMD Pharmaceuticals, Durham, NC. 
vv Phenyl/Chloroform/Isoamyl, Fisher Scientific International Inc, Hampton, NH. 
ww Ammonium acetate, Sigma Chemical Co, St Louis, MO. 
xx Savant SpeedVac Instrument, Global Medical Instrumentation Inc, Ramsey, MN. 
yy Whatman GenSpin™ Genomic DNA Purification Kit, Lablink Scientific Supply Inc, 
Mobile AL. 
zz Puregene DNA Purification Kit, Gentra Systems Inc, Minneapolis, MN. 
aaa ChargeSwitch® gDNA kit, Invitrogen Co, Carlsbad, CA. 
bbb Lysozyme, Sigma Chemical Co, St Louis, MO.  
ccc Sodium hydroxide, Sigma Chemical Co, St Louis, MO. 
ddd Sodium acetate, Sigma Chemical Co, St Louis, MO. 
eee Poly acryl carrier, Molecular Research Center, Cincinnati, OH. 
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APPENDIX A
 Table 6.  Median (interquartile range) values for the concentrations of total R. equi and virulent R. equi, and the proportion of 
virulent R. equi in 171 fecal samples from 135 mares collected during 2004 and 2005 from a farm in central Kentucky. 
 
Sample  Concentration of R. equi (cfu/g)   Concentration of virulent R. equi (cfu/g)  Proportion of virulent R. equi (%)
     2004  2005  P*  2004  2005  P*  2004  2005 P* 
2 weeks prior  1,525 (1,100-2,206)2,450 (1,225-7,500)0.0040  160 (74-252) 125 (50-504) 1.000  11 (6-15)  6 (3-10) 0.0216 
   to foaling 
 
1 week prior 1,225 (950-1,819) 2,450 (1,225-3,800)<0.0001  115 (52-211) 125 (51-276) 0.7700  9. (5-16)  7 (3-10) 0.0385 
   to foaling 
 
Foaling date 1,262 (750-1,969) 2,450 (1,038-9,625)<0.0001  120 (54-226) 100 (25-290) 1.000  10 (3-16)  5 (3-8) 0.0045 
 
1 week after 1,475 (762-3,000) 2,500 (800-10,500) 0.0492  70 (0-198) 98 (25-502) 0.7700  5 (0-12)  4 (1-8) 0.7700 
   foaling   
 
* P values adjusted for multiple comparison; results of significance testing were similar without adjustment (ie, classification of any 
comparison as significant was not altered by adjustment, only the magnitude of the associated P value was changed) 
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Table 7.  Median (interquartile range) values for the concentrations of total R. equi and virulent R. equi, and the proportion of 
virulent R. equi in fecal samples collected from 94 mares from a breeding farm in Kentucky during 2004 by disease status of their 
foals. (Affected group = dam’s foal was affected by R. equi pneumonia [N=29]; Unaffected group = dam’s foal was not affected by 
R. equi pneumonia [N=65])  
 
Sample  Concentration of R. equi (cfu/g)   Concentration of virulent R. equi (cfu/g)  Proportion of virulent R. equi (%)
     Affected   Unaffected     P  Affected         Unaffected   P   Affected       Unaffected P 
2 weeks prior  1,525 (1,150-2,144)  1,525 (1,019-2,225) 0.7859  170 (90-215)      158 (69-260)  0.8751   11 (6-15)         11 (6-15) 0.9932 
   to foaling 
 
1 week prior 1,175 (775-1,450)   1,300 (975-1,825)    0.3185  100 (60-180)      125 (50-240)  0.5254  11. (5-18)          9 (5-15) 0.4733 
   to foaling 
 
Foaling date 1,225 (794-1,556)   1,350 (750-2,156)    0.3616  110 (55-176)      135 (49-264)  0.5538  10 (4-16)          10 (3-16) 0.9999 
 
1 week after 1,912 (988-3,106)   1,450 (562-2,800)    0.4288  48 (0-141)          125 (0-208)   0.4195  5 (1-10)           5 (0-12) 0.9895 
   foaling   
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Table 8.  Median (interquartile range) values for the concentrations of total R. equi and virulent R. equi, and the proportion of 
virulent R. equi in fecal samples collected from 77 mares from a breeding farm in Kentucky during 2005 by disease status of their 
foals. (Affected group = dam’s foal was affected by R. equi pneumonia {N=24]; Unaffected group = dam’s foal was not affected by 
R. equi pneumonia [N=53])  
 
Sample  Concentration of R. equi (cfu/g)   Concentration of virulent R. equi (cfu/g)  Proportion of virulent R. equi (%)
     Affected           Unaffected       P  Affected   Unaffected P  Affected    Unaffected P 
2 weeks prior  1,812 (1,025-6,375)  2,675 (1,475-7,500)   0.1887 75 (50-312) 150 (73-748) 0.2391  6 (4-9)    6 (3-12) 0.9255 
  to foaling 
 
1 week prior 2,050 (988-3,212)   2,525 (1,512-3,975)   0.3699 125 (50-275) 150 (75-367) 0.5521  6. (4-9)    7 (3-10) 0.7771 
   to foaling 
 
Foaling date 2,250 (1,588-4,088)  2,962  (994-10,312)   0.5006 101 (25-239) 100 (25-565) 0.7558  5 (2-7)    5 (3-9)  0.7709 
 
1 week after 1,825 (788-14,125)   2,600 (1,481-10,188) 0.6744 125 (0-627) 87 (25-438) 0.8726  4 (0-8)    4 (1-7)  0.4190 
 
 
 
 
 
 
 
 
   foaling   
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Table 9. R. equi pneumonia status vs. R. equi growth in foal 2004 foaling date (FD) 
samples 
  
                                                 Developed R. equi pneumonia 
 
Feces grew  
   R. equi 
     
 Yes  No Total 
Yes 1 8 9 
No 28 57 85 
Total 29 65 94 
 
 
Table 10. R. equi pneumonia status vs. R. equi growth in foal 2004 1 week after foaling 
(1WAF) samples 
                                                   
Developed R. equi pneumonia 
 
 Yes No Total 
Yes 13 23 36 
No 16 42 58 
Total 29 65 94 
 
Feces grew 
   R. equi 
 
*The one foal that grew R. equi in the 2004 foaling date (FD) sample and developed 
disease, failed to grow R. equi in its 2004 1WAF specimen. 
 
                                                                             
 
Table 11. R. equi pneumonia status vs. R. equi growth in foal 2005 foaling date (FD) 
samples 
 
  Developed R. equi pneumonia 
  
 
Feces grew 
   R. equi  
 
 Yes No Total 
Yes 3 4 7 
No 20 50 70 
Total 23 54 77 
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Table 12. R. equi pneumonia status vs. R. equi growth in foal 2005 1 week after foaling 
(1WAF) samples 
 
  Developed R. equi pneumonia 
  
Feces grew  
   R. equi  
 
 Yes No Total 
Yes 13 32 45 
No 10 22 32 
Total 23 54 77 
*Two foals grew R. equi in their 2005 foaling date (FD) sample and developed disease 
but failed to grow R. equi in their 1WAF samples. 
*One foal grew R. equi in both its FD and 1WAF samples and developed disease. 
 
 
 
Table 13. R. equi pneumonia status vs. detection of virulent R. equi growth (colony 
immunoblot) in foal 2004 1 week after foaling (1WAF) samples 
 
                 Developed R. equi pneumonia 
 
 Yes  No Total 
Yes 5 12 17 
No 8 11 19 
Total 13 23 36 
 
Feces contained  
virulent R. equi 
             
                                                               
*Table includes only those foals that grew R. equi to begin with. 
 
 
 
Table 14. R. equi pneumonia status vs. detection of virulent R. equi growth (colony 
immunoblot) in foal 2005 1 week after foaling (1WAF) samples 
 
  Developed R. equi pneumonia 
 
Feces contained 
virulent R. equi 
 
  
 Yes No Total 
Yes 3 4 7 
No 10 28 38 
Total 13 32 45 
*Table includes only those foals that grew R. equi to begin with. 
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Table 15. R. equi pneumonia status vs. detection of virulent R. equi growth as determined 
using RT-PCR in foal 2005 foaling date (FD) and 1 week after foaling (1WAF) samples 
 
  Developed R. equi pneumonia 
 
 Yes No Total 
Yes 4 6 10 
No 12 30 42 
Total 16 36 52 
 
Feces contained 
virulent R. equi  
 
 
 
Table 16. Foal 2004 samples that contained virulent R. equi detected using colony 
immunoblot method 
 
Collection time 
 
 foaling date (FD) 1 week after 
foaling (1WAF) 
Total 
Did 1 17 18 
Didn’t 93 77 170 
Total 94 94 188 
 
Grew virulent  
     R. equi 
 
 
 
* The foal that had the 1 foaling date (FD) sample that did grow virulent R. equi, was 
negative for disease. 
 
 
 
Table 17. Foal 2005 samples that contained virulent R. equi detected using either the 
colony immunoblot or RT-PCR method 
 
Collection time 
 
 foaling date (FD) 1 week after 
foaling (1WAF) 
Total 
Did 0 13 13 
Didn’t 77 64 141 
Total 77 77 154 
 
Grew virulent 
     R. equi 
 
 
 
*5/13 foals that grew virulent R. equi in their 1WAF sample, developed disease 
*A sample was considered to contain virulent R. equi if either or both detection methods 
detected virulent R. equi. 
*A sample was considered not to contain virulent R. equi only if both methods failed to 
detect virulent R. equi 
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FIG. 1.  Distribution of the total fecal concentrations of R. equi from 94 mares during the 
foaling day sampling time-point in 2004.  No seasonal pattern was observed for temporal 
shedding.  All other sampling time-points from 2004 appeared similar in distribution to 
this figure.  
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FIG. 2.  Distribution of the total fecal concentrations of R. equi from 77 mares during the 
foaling day sampling time-point in 2005.  No seasonal pattern was observed for temporal 
shedding.  All other sampling time-points from 2005 appeared similar in distribution to 
this figure.  
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FIG. 3.  Boxplots of the distribution of the proportion of virulent R. equi in mare fecal 
specimens 2 weeks prior to foaling.  The difference in the distribution of the proportions 
of virulent isolates between the two sampling years was significantly different (P = 
0.0216).  Due to the difference in how the specimens were treated before culturing (i.e., 
frozen in 2004 and processed fresh on arrival in 2005), samples from each year were 
analyzed separately.  P.2WPvirulent is the percentage (proportion X 100) of virulent R. 
equi isolates in mare fecal specimens.  Looking at the boxplots, the thick bar is the 
median, ends of the boxes are the 25th and 75th percentiles, any outliers are marked with a 
circle and extreme outliers are marked with an asterisk.  The outliers are cases with the 
values between 1.5 and 3 box-lengths from the 75th percentile or 25th percentile.  The 
extreme outliers are cases with the values more than 3 box-lengths from the 75th 
percentile or 25th percentile. 
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FIG. 4.  Boxplots describing the distribution of the fecal proportions of virulent R. equi 
in mare fecal specimens collected 2 weeks prior to foaling, according to year and disease 
status of the foal.  “0” indicates that the foal did not develop R. equi pneumonia and “1” 
indicates that it did develop R. equi pneumonia.  When comparing within a year, the 
proportion virulent are similar for mares with affected or unaffected foals.  When looking 
between years, it is evident that mares in 2004 had higher proportions of virulent R. equi 
in their feces.  This was most likely due to smaller total concentrations of R. equi grown 
because of freezing the specimens upon arrival in 2004, leading to some unstable point 
estimates of these proportion data.  No significant difference between disease status was 
detected in either 2004 (P = 0.9932) or 2005 (P = 0.9255).  P.2WPvirulent is the 
percentage (proportion X 100) of virulent R. equi isolates in mare fecal specimens.  
Looking at the boxplots, the thick bar is the median, ends of the boxes are the 25th and 
75th percentiles, any outliers are marked with a circle and extreme outliers are marked 
with an asterisk.  The outliers are cases with the values between 1.5 and 3 box-lengths 
from the 75th percentile or 25th percentile.  The extreme outliers are cases with the values 
more than 3 box-lengths from the 75th percentile or 25th percentile. 
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FIG. 5.  Boxplots of the distribution of the proportion of virulent R. equi in mare fecal 
specimens 1 week prior to foaling.  The difference in the distribution of the proportion of 
virulent isolates between the two sampling years was significantly different (P = 0.0385).  
Due to the difference in how the specimens were treated before culturing (i.e., frozen in 
2004 and processed fresh on arrival in 2005), samples from each year were analyzed 
separately.  P.1WPvirulent is the percentage (proportion X 100) of virulent R. equi 
isolates in mare fecal specimens.  Looking at the boxplots, the thick bar is the median, 
ends of the boxes are the 25th and 75th percentiles, any outliers are marked with a circle 
and extreme outliers are marked with an asterisk.  The outliers are cases with the values 
between 1.5 and 3 box-lengths from the 75th percentile or 25th percentile.  The extreme 
outliers are cases with the values more than 3 box-lengths from the 75th percentile or 25th 
percentile. 
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FIG. 6.  Boxplots describing the distribution of the proportions of virulent R. equi in 
mare fecal specimens collected 1 week prior to foaling, according to year and disease 
status of the foal.  “0” indicates that the foal did not develop R. equi pneumonia and “1” 
indicates that it did develop R. equi pneumonia.  When comparing within a year, the 
proportion virulent are similar for mares with affected or unaffected foals.  When looking 
between years, it is evident that mares in 2004 had higher proportions of virulent R. equi 
in their feces.  This was most likely due to smaller total concentrations of R. equi grown 
because of freezing the specimens upon arrival in 2004, leading to some unstable point 
estimates of these proportion data.  No significant difference between disease status was 
detected in either 2004 (P = 0.4733) or 2005 (P = 0.7771).  P.1WPvirulent is the 
percentage (proportion X 100) of virulent R. equi isolates in mare fecal specimens.  
Looking at the boxplots, the thick bar is the median, ends of the boxes are the 25th and 
75th percentiles, any outliers are marked with a circle and extreme outliers are marked 
with an asterisk.  The outliers are cases with the values between 1.5 and 3 box-lengths 
from the 75th percentile or 25th percentile.  The extreme outliers are cases with the values 
more than 3 box-lengths from the 75th percentile or 25th percentile. 
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FIG. 7.  Boxplots of the distribution of the proportion of virulent R. equi in mare fecal 
specimens collected on the foaling day.  The difference in the distribution of the 
proportion of virulent isolates between the two sampling years was significant (P = 
0.0045).  Due to the difference in how the specimens were treated before culturing (i.e., 
frozen in 2004 and processed fresh on arrival in 2005), samples from each year were 
analyzed separately.  P.FDvirulent is the percentage (proportion X 100) of virulent R. 
equi isolates in mare fecal specimens.  Looking at the boxplots, the thick bar is the 
median, ends of the boxes are the 25th and 75th percentiles, any outliers are marked with a 
circle and extreme outliers are marked with an asterisk.  The outliers are cases with the 
values between 1.5 and 3 box-lengths from the 75th percentile or 25th percentile.  The 
extreme outliers are cases with the values more than 3 box-lengths from the 75th 
percentile or 25th percentile. 
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FIG. 8.  Boxplots describing the distribution of the proportions of virulent R. equi in 
mare fecal specimens collected on the day of foaling, according to year and disease status 
of the foal.  “0” indicates that the foal did not develop R. equi pneumonia and “1” 
indicates that it did develop R. equi pneumonia.  When comparing within a year, the 
proportion virulent were similar for mares with affected or unaffected foals.  When 
looking between years, it was evident that mares in 2004 had higher proportions of 
virulent R. equi in their feces.  This was most likely due to smaller total concentrations of 
R. equi grown because of freezing the specimens upon arrival in 2004, leading to some 
unstable point estimates of these proportion data.  No significant difference between 
disease status was detected in either 2004 (P = 0.9999) or 2005 (P = 0.7709).  
P.FDvirulent is the percentage (proportion X 100) of virulent R. equi isolates in mare 
fecal specimens.  Looking at the boxplots, the thick bar is the median, ends of the boxes 
are the 25th and 75th percentiles, any outliers are marked with a circle and extreme 
outliers are marked with an asterisk.  The outliers are cases with the values between 1.5 
and 3 box-lengths from the 75th percentile or 25th percentile.  The extreme outliers are 
cases with the values more than 3 box-lengths from the 75th percentile or 25th percentile. 
 
71 
 
 
 
 
FIG. 9.  Boxplots of the distribution of the proportion of virulent R. equi in mare fecal 
specimens collected 1 week after foaling.  The difference in the distribution of the 
proportion of virulent R. equi between the two sampling years was not significant (P = 
0.7700).  Due to the difference in how the specimens were treated before culturing (i.e., 
frozen in 2004 and processed fresh on arrival in 2005), samples from each year were 
analyzed separately.  P.1WAFvirulent is the percentage (proportion X 100) of virulent R. 
equi isolates in mare fecal specimens.  Looking at the boxplots, the thick bar is the 
median, ends of the boxes are the 25th and 75th percentiles, any outliers are marked with a 
circle and extreme outliers are marked with an asterisk.  The outliers are cases with the 
values between 1.5 and 3 box-lengths from the 75th percentile or 25th percentile.  The 
extreme outliers are cases with the values more than 3 box-lengths from the 75th 
percentile or 25th percentile. 
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FIG. 10.  Boxplots describing the distribution of the fecal proportions of virulent R. equi 
in mare fecal specimens collected 1 week after foaling, according to year and disease 
status of the foal.  “0” indicates that the foal did not develop R. equi pneumonia and “1” 
indicates that it did develop R. equi pneumonia.  When comparing within a year, the 
proportion virulent are similar for mares with affected or unaffected foals.  When looking 
between years, it is evident that mares in 2004 had higher proportions of virulent R. equi 
in their feces.  This was most likely due to smaller total concentrations of R. equi grown 
because of freezing the specimens upon arrival in 2004, leading to some unstable point 
estimates of the proportion data.  No significant difference between disease status was 
detected in either 2004 (P = 0.9895) or 2005 (P = 0.4190).  P.1WAFvirulent is the 
percentage (proportion X 100) of virulent R. equi isolates in mare fecal specimens.  
Looking at the boxplots, the thick bar is the median, ends of the boxes are the 25th and 
75th percentiles, any outliers are marked with a circle and extreme outliers are marked 
with an asterisk.  The outliers are cases with the values between 1.5 and 3 box-lengths 
from the 75th percentile or 25th percentile.  The extreme outliers are cases with the values 
more than 3 box-lengths from the 75th percentile or 25th percentile. 
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FIG. 11.  Boxplots describing the distributions of total concentrations (cfu/g) of R. equi 
in all mare fecal specimens collected (2-weeks prior to foaling, 1-week prior to foaling, 
day of foaling, and 1-week after foaling) over both years (2004 vs. 2005).  Overall, 
concentrations were much lower in 2004 (due to freezing), than in 2005.  Ranges and 
medians were all higher for the 2005 data.  The lower total concentrations of R. equi in 
2004 could help explain why the proportion virulent for 2004 was so much higher.  Less 
growth of R. equi by culture means that an extra virulent colony, determined by the 
immunoblotting assay, would yield a greater proportion virulent in the sample.  Looking 
at the boxplots, the thick bar is the median, ends of the boxes are the 25th and 75th 
percentiles, any outliers are marked with a circle and extreme outliers are marked with an 
asterisk.  The outliers are cases with the values between 1.5 and 3 box-lengths from the 
75th percentile or 25th percentile.  The extreme outliers are cases with the values more 
than 3 box-lengths from the 75th percentile or 25th percentile. 
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FIG. 12.  Boxplots describing the distributions of the proportion of virulent R. equi by 
sample and by year.  Larger ranges and slightly higher medians were observed for the 
2004 specimens.  This could be attributed to the freezing of the fecal specimens in 2004, 
leading to less R. equi growth and having an effect on the proportion virulent.  No 
significant difference in proportions was determined.  Looking at the boxplots, the thick 
bar is the median, ends of the boxes are the 25th and 75th percentiles, any outliers are 
marked with a circle and extreme outliers are marked with an asterisk.  The outliers are 
cases with the values between 1.5 and 3 box-lengths from the 75th percentile or 25th 
percentile.  The extreme outliers are cases with the values more than 3 box-lengths from 
the 75th percentile or 25th percentile. 
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FIG. 13.  Colony-blot results showing intensity of virulent R. equi colonies cultured from 
mare feces.  Since there are many types organisms shed in equine feces, there is often 
growth of organisms other than R. equi on plates that can vary in density.  The modified 
NANAT agar medium is effective at keeping this growth minimal, which makes the 
immunoblotted membranes easier to analyze (Figure A).  The foci of background that can 
occasionally be observed with the cultured feces are grey in color and thus can be easily 
distinguished from virulent R. equi colonies appearing blue (Figure B). The numbers that 
appear in the lower right corner of each picture are the number of virulent colonies that 
were counted on the membrane. 
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